Commodore Capital LP - 30 Sep 2025 SCHEDULE 13G/A Report for Viridian Therapeutics, Inc.\DE Common Stock, $0.01 par value (VRDN)

Filing Manager: Commodore Capital LP
Reporting Manager: Commodore Capital LP
Security: Viridian Therapeutics, Inc.\DE Common Stock, $0.01 par value
Symbol: VRDN
Shares outstanding: 82,051,282 shares
Disclosed Ownership: 3,200,000 shares
Ownership: 3.9%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 17:17:25 UTC
Date of event: 30 Sep 2025
Previous filing: 11 Apr 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Commodore Capital LP	3.9%	3,200,000	0	3,200,000	Michael Kramarz	Managing Partner
Commodore Capital Master LP	3.9%	3,200,000	0	3,200,000	Michael Kramarz	Managing Partner